Ms. magazine  -- more than a magazine a movement

SIGN UP FOR MS. DIGEST, JOBS, NEWS AND ALERTS

FEMINIST WIRE NEWSBRIEFS

ABOUT
SEE CURRENT ISSUE
SHOP MS. STORE
MS. IN THE CLASSROOM
FEMINIST DAILY WIRE
FEMINIST RESOURCES
PRESS
JOBS AT MS.
READ BACK ISSUES
CONTACT
RSS (XML)
 
feminist wire | daily newsbriefs

June-18-04

Top FDA Scientists Criticize Rejection of EC Over the Counter

Top Food and Drug Administration (FDA) scientists wrote an internal memo criticizing FDA leadership for rejecting Barr Laboratories' application for over-the-counter status for its emergency contraceptive Plan B. The internal FDA memo reveals that all staff reviewers agreed that the application met with the agency’s usual standards for over-the-counter status, according to the Washington Post. Two expert FDA advisory panels also voted 23-4 for approval in December.

The FDA rejected Barr Laboratories’ application on May 6, citing concerns that there was not enough information about the effects of EC on women under the age of 16. John Jenkins, director of the FDA Office of New Drugs wrote in the internal memo, “The agency has not [previously] distinguished the safety and efficacy of Plan B and other forms of hormonal contraception among different ages of women of childbearing potential, and I am not aware of any compelling scientific reason for such a distinction in this case,” the Post reports. FDA staff also expressed concern that the decision was also based on non-medical concerns about teenage sexual behavior and moral judgments about propriety, according to another internal memo, the Post reports. As part of their analysis, staff reviewers determined that studies indicated there would be no change in teenage sexual behavior, no additional risk of sexually transmitted diseases, and no basis for concluding that Plan B would be any less safe or effective for teenagers than for older women.

According to the Post, Members of Congress have called for hearings due to the irregularities in the FDA decision, and earlier this week, the Associated Press reported that the American Medical Association voted without any debate on a resolution criticizing the FDA’s decision and voicing support for over-the-counter status for emergency contraception.

The Feminist Majority Foundation leads a national drive on college campuses to increase the availability of EC for young women. Emergency contraception is safe, and most effective if taken within 24 hours after unprotected intercourse, contraceptive failure, or rape.

TAKE ACTION Urge the FDA to Stop Playing Politics With Women’s Lives

DONATE to FMF and support our campaign for over the counter status of emergency contraception

Media Resources: Associated Press 6/15/04; Washington Post 6/18/04; Feminist Daily News Wire


© Feminist Majority Foundation, publisher of Ms. magazine

If you liked this story, consider making a tax-deductible donation to support Ms. magazine.

 

 

Send to a Friend
Their
Your
Comments
(optional)


More Feminist News

4/22/2014 US Ranks 16th in 2014 Social Progress Index - The Social Progress Imperative recently released its 2014 Social Progress Index, ranking the United States in 16th place among 132 countries. Harvard Business School Professor Michael Porter, a Republican who led the report team, told CNN's Fareed Zakaria that he was surprised by the ranking. . . .
 
4/22/2014 Florida Supreme Court Recognizes Anti-Discrimination Protections for Pregnant Workers - The Florida State Supreme Court ruled last week that pregnancy discrimination is a form of sex discrimination under Florida employment law. The 6-1 decision allows Peguy Delva to proceed with her lawsuit against her employer, real estate developer Continental Group. . . .
 
4/21/2014 Arizona Governor Signs Bill Allowing Suprise Inspections of Abortion Clinics - Arizona Governor Jan Brewer signed a bill into law last week allowing state health authorities to conduct surprise inspections of abortion clinics without a warrant. HB 2284 repeals an Arizona law that requires a judge to give approval for inspections of abortion clinics. . . .